Story perspectives

UnitedHealth Group Under DOJ Investigation for Medicare Fraud

7/24/2025

23 4

Summary

Story summary

UnitedHealth Group faces a Department of Justice investigation regarding potential Medicare billing fraud.
The company is cooperating with criminal and civil inquiries and has started a third-party policy review.
Following the announcement, UnitedHealth's stock dropped over 2%, compounding a challenging year of leadership shifts and rising expenses.
The investigation stems from allegations of inflated diagnoses in the Medicare Advantage program.
UnitedHealth asserts confidence in its practices, supported by independent audits verifying accuracy.

History

Historical Context

The Medicare Advantage program, launched by the Centers for Medicare & Medicaid Services in 2014, has faced scrutiny over billing practices, echoing past healthcare controversies. In 2021, UnitedHealth Group reported $157 billion in revenue, underscoring its market influence. Ongoing investigations into potential Medicare fraud may prompt stricter regulations, impacting compliance and operational practices in the healthcare sector.

1 of 2

Story summary

UnitedHealth Group faces a Department of Justice investigation regarding potential Medicare billing fraud.
The company is cooperating with criminal and civil inquiries and has started a third-party policy review.
Following the announcement, UnitedHealth's stock dropped over 2%, compounding a challenging year of leadership shifts and rising expenses.
The investigation stems from allegations of inflated diagnoses in the Medicare Advantage program.
UnitedHealth asserts confidence in its practices, supported by independent audits verifying accuracy.

1 / 2